Puelles, V. G. et al. Multiorgan and renal tropism of SARS-CoV-2. N. Engl. J. Med. 383, 590–592 (2020).
Google Scholar
Lamers, M. M. & Haagmans, B. L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 20, 270–284 (2022).
Google Scholar
Peng, L. et al. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. J. Med. Virol. 92, 1676–1680 (2020).
Google Scholar
Wölfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465–469 (2020).
Google Scholar
Zhang, W. et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg. Microbes Infect. 9, 386–389 (2020).
Google Scholar
Pérez-Bartolomé, F. & Sánchez-Quirós, J. Ocular manifestations of SARS-CoV-2: literature review. Arch. Soc. Esp. Oftalmol. 96, 32–40 (2021).
Google Scholar
Vetter, P. et al. Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series. mSphere https://doi.org/10.1128/mSphere.00827-20 (2020).
Google Scholar
Jeong, H. W. et al. Viable SARS-CoV-2 in various specimens from COVID-19 patients. Clin. Microbiol. Infect. 26, 1520–1524 (2020).
Google Scholar
Cerrada-Romero, C. et al. Excretion and viability of SARS-CoV-2 in feces and its association with the clinical outcome of COVID-19. Sci. Rep. 12, 7397 (2022).
Google Scholar
Dergham, J. & Delerce, J. Isolation of viable SARS-CoV-2 virus from feces of an immunocompromised patient suggesting a possible fecal mode of transmission. J. Clin. Med. https://doi.org/10.3390/jcm10122696 (2021).
Google Scholar
Xiao, F. et al. Infectious SARS-CoV-2 in feces of patient with severe COVID-19. Emerg. Infect. Dis. 26, 1920–1922 (2020).
Google Scholar
Sun, J. et al. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg. Microbes Infect. 9, 991–993 (2020).
Google Scholar
Colavita, F. et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann. Intern. Med. 173, 242–243 (2020).
Google Scholar
Matsuyama, S. et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl Acad. Sci. USA 117, 7001–7003 (2020).
Google Scholar
Case, J. B., Bailey, A. L., Kim, A. S., Chen, R. E. & Diamond, M. S. Growth, detection, quantification, and inactivation of SARS-CoV-2. Virology 548, 39–48 (2020).
Google Scholar
Baggen, J., Vanstreels, E., Jansen, S. & Daelemans, D. Cellular host factors for SARS-CoV-2 infection. Nat. Microbiol. 6, 1219–1232 (2021).
Google Scholar
Chu, H. et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe 1, e14–e23 (2020).
Google Scholar
van Kampen, J. J. A. et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat. Commun. 12, 267 (2021).
Google Scholar
Bruce, E. A. et al. Predicting infectivity: comparing four PCR-based assays to detect culturable SARS-CoV-2 in clinical samples. EMBO Mol. Med. 14, e15290 (2022).
Google Scholar
Essaidi-Laziosi, M. & Perez Rodriguez, F. J. Estimating clinical SARS-CoV-2 infectiousness in Vero E6 and primary airway epithelial cells. Lancet Microbe 2, e571 (2021).
Google Scholar
Liu, R. et al. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin. Chim. Acta 505, 172–175 (2020).
Google Scholar
Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eur. Surveill. https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045 (2020).
Google Scholar
Bullard, J. et al. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin. Infect. Dis. 71, 2663–2666 (2020).
Google Scholar
Jefferson, T., Spencer, E. A., Brassey, J. & Heneghan, C. Viral cultures for coronavirus disease 2019 infectivity assessment: a systematic review. Clin. Infect. Dis. 73, e3884–e3899 (2021).
Google Scholar
Puhach, O. et al. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Nat. Med. 28, 1491–1500 (2022).
Google Scholar
van Kasteren, P. B. et al. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J. Clin. Virol. 128, 104412 (2020).
Google Scholar
Bentley, E. et al. Collaborative study for the establishment of a WHO international standard for SARS-CoV-2 RNA (WHO, 2020).
Zou, L. et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 382, 1177–1179 (2020).
Google Scholar
Killingley, B. et al. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nat. Med. 28, 1031–1041 (2022).
Google Scholar
Yu, F. et al. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. Clin. Infect. Dis. 71, 793–798 (2020).
Google Scholar
European Centre for Disease Prevention and Control & World Health Organization Regional Office for Europe. Methods for the detection and identification of SARS-CoV-2 variants: second update, August 2022 (WHO, 2022).
Ke, R. et al. Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveals limited infectious virus shedding and restricted tissue distribution. Open Forum Infect. Dis. 9, ofac192 (2022).
Google Scholar
Ke, R. et al. Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness. Nat. Microbiol. 7, 640–652 (2022).
Google Scholar
Pekosz, A. et al. Antigen-based testing but not real-time polymerase chain reaction correlates with severe acute respiratory syndrome coronavirus 2 viral culture. Clin. Infect. Dis. 73, e2861–e2866 (2021).
Google Scholar
Monel, B. et al. Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-Alpha or Alpha SARS-CoV-2 variants: an observational retrospective study. EBioMedicine 73, 103637 (2021).
Google Scholar
Kirby, J. E. et al. SARS-CoV-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort. Clin. Microbiol. Infect. https://doi.org/10.1016/j.cmi.2022.07.010 (2022).
Google Scholar
Pickering, S. et al. Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study. Lancet Microbe 2, e461–e471 (2021).
Google Scholar
Tariq, M. et al. Viable severe acute respiratory syndrome coronavirus 2 isolates exhibit higher correlation with rapid antigen assays than subgenomic RNA or genomic RNA. Front. Microbiol. 12, 718497 (2021).
Google Scholar
Chu, V. T. et al. Comparison of home antigen testing with RT-PCR and viral culture during the course of SARS-CoV-2 infection. JAMA Intern. Med. 182, 701–709 (2022).
Google Scholar
Albert, E. et al. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for COVID-19 diagnosis in primary healthcare centres. Clin. Microbiol. Infect. 27, 472.e7–472.e10 (2021).
Google Scholar
Ford, L. et al. Epidemiologic characteristics associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen-based test results, real-time reverse transcription polymerase chain reaction (rRT-PCR) cycle threshold values, subgenomic RNA, and viral culture results from university testing. Clin. Infect. Dis. 73, e1348–e1355 (2021).
Google Scholar
Berger, A. et al. Diagnostic accuracy of two commercial SARS-CoV-2 antigen-detecting rapid tests at the point of care in community-based testing centers. PLoS ONE 16, e0248921 (2021).
Google Scholar
Brümmer, L. E. et al. Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: a living systematic review and meta-analysis. PLoS Med. 18, e1003735 (2021).
Google Scholar
Ngo Nsoga, M. T. et al. Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2. PLoS ONE 16, e0253321 (2021).
Google Scholar
Korenkov, M. et al. Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals. J. Clin. Microbiol. 59, e0089621 (2021).
Google Scholar
Yamayoshi, S. et al. Comparison of rapid antigen tests for COVID-19. Viruses 12, 1420 (2020).
Google Scholar
McKay, S. L. et al. Performance evaluation of serial SARS-CoV-2 rapid antigen testing during a nursing home outbreak. Ann. Intern. Med. 174, 945–951 (2021).
Google Scholar
Nordgren, J. et al. SARS-CoV-2 rapid antigen test: high sensitivity to detect infectious virus. J. Clin. Virol. 140, 104846 (2021).
Google Scholar
Fernandez-Montero, A. & Argemi, J. Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values. EClinicalMedicine 37, 100954 (2021).
Google Scholar
Currie, D. W. et al. Relationship of SARS-CoV-2 antigen and reverse transcription PCR positivity for viral cultures. Emerg. Infect. Dis. 28, 717–720 (2022).
Google Scholar
Corman, V. M. et al. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study. Lancet Microbe 2, e311–e319 (2021).
Google Scholar
Lopera, T. J. & Alzate-Ángel, J. C. The usefulness of antigen testing in predicting contagiousness in COVID-19. Microbiol. Spectr. 10, e0196221 (2022).
Google Scholar
Osterman, A. et al. Impaired detection of Omicron by SARS-CoV-2 rapid antigen tests. Med. Microbiol. Immunol. 211, 105–117 (2022).
Google Scholar
Galliez, R. M. et al. Evaluation of the Panbio COVID-19 antigen rapid diagnostic test in subjects infected with Omicron using different specimens. Microbiol. Spectr. 10, e0125022 (2022).
Google Scholar
Raïch-Regué, D. et al. Performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests for Omicron and other variants of concern. Front. Microbiol. 13, 810576 (2022).
Google Scholar
van Ogtrop, M. L., van de Laar, T. J. W., Eggink, D., Vanhommerig, J. W. & van der Reijden, W. A. Comparison of the performance of the Panbio COVID-19 antigen test in SARS-CoV-2 B.1.1.7 (Alpha) variants versus non-B.1.1.7 variants. Microbiol. Spectr. 9, e0088421 (2021).
Google Scholar
Lindner, A. K. et al. Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected nasal swab versus professional-collected nasopharyngeal swab. Eur. Respir. J. 57, 2003961 (2021).
Google Scholar
Meiners, L. & Horn, J. SARS-CoV-2 rapid antigen test sensitivity and viral load in freshly symptomatic hospital employees, December 2020 to February 2022. Preprint at https://doi.org/10.2139/ssrn.4099425 (2022).
He, X. et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 26, 672–675 (2020).
Google Scholar
Néant, N. et al. Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort. Proc. Natl Acad. Sci. USA 118, e2017962118 (2021).
Google Scholar
Owusu, D. et al. Persistent SARS-CoV-2 RNA shedding without evidence of infectiousness: a cohort study of individuals with COVID-19. J. Infect. Dis. 224, 1362–1371 (2021).
Google Scholar
Cevik, M. et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe 2, e13–e22 (2021).
Google Scholar
Chen, X. et al. Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19. Int. J. Infect. Dis. 98, 252–260 (2020).
Google Scholar
Kim, S. M. & Hwang, Y. J. Prolonged SARS-CoV-2 detection and reversed RT-PCR results in mild or asymptomatic patients. Infect. Dis. 53, 31–37 (2021).
Google Scholar
Talmy, T. & Tsur, A. Duration of SARS-CoV-2 detection in Israel Defense Forces soldiers with mild COVID-19. J. Med. Virol. 93, 608–610 (2021).
Google Scholar
Singanayagam, A. et al. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill. https://doi.org/10.2807/1560-7917.ES.2020.25.32.2001483 (2020).
Perera, R. et al. SARS-CoV-2 virus culture and subgenomic RNA for respiratory specimens from patients with mild coronavirus disease. Emerg. Infect. Dis. 26, 2701–2704 (2020).
Google Scholar
Killerby, M. E. et al. Shedding of culturable virus, seroconversion, and 6-month follow-up antibody responses in the first 14 confirmed cases of coronavirus disease 2019 in the United States. J. Infect. Dis. 224, 771–776 (2021).
Google Scholar
Glans, H. et al. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses. BMC Infect. Dis. 21, 494 (2021).
Google Scholar
Badu, K. et al. SARS-CoV-2 viral shedding and transmission dynamics: implications of WHO COVID-19 discharge guidelines. Front. Med. 8, 648660 (2021).
Google Scholar
Munker, D. et al. Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients. Eur. Respir. J. 58, 2002724 (2021).
Google Scholar
Folgueira, M. D. & Luczkowiak, J. Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19. Clin. Microbiol. Infect. 27, 886–891 (2021).
Google Scholar
Kim, M. C. et al. Duration of culturable SARS-CoV-2 in hospitalized patients with Covid-19. N. Engl. J. Med. 384, 671–673 (2021).
Google Scholar
Chen, P. Z. et al. SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19. eLife https://doi.org/10.7554/eLife (2021).
Google Scholar
Cunha, M. D. P. et al. Atypical prolonged viral shedding with intra-host SARS-CoV-2 evolution in a mildly affected symptomatic patient. Front. Med. 8, 760170 (2021).
Google Scholar
Aydillo, T. et al. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N. Engl. J. Med. 383, 2586–2588 (2020).
Google Scholar
Caillard, S., Benotmane, I., Gautier Vargas, G., Perrin, P. & Fafi-Kremer, S. SARS-CoV-2 viral dynamics in immunocompromised patients. Am. J. Transpl. 21, 1667–1669 (2021).
Google Scholar
Roedl, K. et al. Viral dynamics of SARS-CoV-2 in critically ill allogeneic hematopoietic stem cell transplant recipients and immunocompetent patients with COVID-19. Am. J. Respir. Crit. Care Med. 203, 242–245 (2021).
Google Scholar
Leung, W. F. et al. COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report. Int. J. Infect. Dis. 114, 178–182 (2022).
Google Scholar
European Centre for Disease Prevention and Control. Rapid risk assessment: assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update (European Centre for Disease Prevention and Control, 2021).
Grant, R. et al. Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: results from a nationwide case–control study in France. Lancet Reg. Health Eur. 13, 100278 (2022).
Google Scholar
Ogata, T. & Tanaka, H. Shorter incubation period among unvaccinated Delta variant coronavirus disease 2019 patients in Japan. Int. J. Environ. Res. Public Health https://doi.org/10.3390/ijerph19031127 (2022).
Google Scholar
Backer, J. A. et al. Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021. Eur. Surveill. https://doi.org/10.2807/1560-7917.ES.2022.27.6.2200042 (2022).
Google Scholar
Takahashi, K. et al. Duration of infectious virus shedding by SARS-CoV-2 Omicron variant-infected vaccinees. Emerg. Infect. Dis. 28, 998–1001 (2022).
Google Scholar
Boucau, J. et al. Duration of shedding of culturable virus in SARS-CoV-2 Omicron (BA.1) infection. N. Engl. J. Med. 387, 275–277 (2022).
Google Scholar
Jones, T. C. et al. Estimating infectiousness throughout SARS-CoV-2 infection course. Science https://doi.org/10.1126/science.abi5273 (2021).
Google Scholar
Li, B. et al. Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant. Nat. Commun. 13, 460 (2022).
Google Scholar
Bolze, A. et al. SARS-CoV-2 variant Delta rapidly displaced variant Alpha in the United States and led to higher viral loads. Cell Rep. Med. 3, 100564 (2022).
Google Scholar
Earnest, R. et al. Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA. Cell Rep. Med. 3, 100583 (2022).
Google Scholar
Luo, C. H. et al. Infection with the SARS-CoV-2 Delta variant is associated with higher recovery of infectious virus compared to the Alpha variant in both unvaccinated and vaccinated individuals. Clin. Infect. Dis. 75, e715–e725 (2021).
Google Scholar
Despres, H. W. et al. Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer: RNA ratio for Delta and Epsilon vs. Alpha variants. Proc. Natl Acad. Sci. USA https://doi.org/10.1073/pnas.2116518119 (2022).
Google Scholar
Hay, J. A. et al. Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: a retrospective cohort study. eLife 11, e81849 (2022).
Google Scholar
Fall, A. et al. The displacement of the SARS-CoV-2 variant Delta with Omicron: an investigation of hospital admissions and upper respiratory viral loads. EbioMedicine https://doi.org/10.1016/j.ebiom.2022.104008 (2022).
Google Scholar
Lentini, A. & Pereira, A. Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 lineage transition in the Swedish population reveals increased viral RNA levels in BA.2 cases. Med 3, 636–664 (2022).
Google Scholar
Qassim, S. H. et al. Effects of BA.1/BA.2 subvariant, vaccination, and prior infection on infectiousness of SARS-CoV-2 Omicron infections. J. Travel Med. 29, taac068 (2022).
Google Scholar
Marking, U. et al. Correlates of protection, viral load trajectories and symptoms in BA.1, BA.1.1 and BA.2 breakthrough infections in triple vaccinated healthcare workers. Preprint at medRxiv https://doi.org/10.1101/2022.04.02.22273333 (2022).
Google Scholar
Wang, Y. et al. Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China. EClinicalMedicine 40, 101129 (2021).
Google Scholar
Siedner, M. J. et al. Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 Delta variant infections. JCI Insight https://doi.org/10.1172/jci.insight.155483 (2022).
Google Scholar
Pierce, C. A. et al. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci. Transl Med. 12, eabd5487 (2020).
Google Scholar
Takahashi, T. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588, 315–320 (2020).
Google Scholar
Bunyavanich, S., Do, A. & Vicencio, A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA 323, 2427–2429 (2020).
Google Scholar
Zheng, S. et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January–March 2020: retrospective cohort study. BMJ 369, m1443 (2020).
Google Scholar
L’Huillier, A. G. & Torriani, G. Culture-competent SARS-CoV-2 in nasopharynx of symptomatic neonates, children, and adolescents. Emerg. Infect. Dis. 26, 2494–2497 (2020).
Google Scholar
Baggio, S. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load in the upper respiratory tract of children and adults with early acute coronavirus disease 2019 (COVID-19). Clin. Infect. Dis. 73, 148–150 (2021).
Google Scholar
Chung, E. et al. Comparison of symptoms and RNA levels in children and adults with SARS-CoV-2 infection in the community setting. JAMA Pediatr. 175, e212025 (2021).
Google Scholar
Han, M. S. et al. Clinical characteristics and viral RNA detection in children with coronavirus disease 2019 in the Republic of Korea. JAMA Pediatr. 175, 73–80 (2021).
Google Scholar
Bellon, M. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load kinetics in symptomatic children, adolescents, and adults. Clin. Infect. Dis. 73, e1384–e1386 (2021).
Google Scholar
Madera, S. et al. Nasopharyngeal SARS-CoV-2 viral loads in young children do not differ significantly from those in older children and adults. Sci. Rep. 11, 3044 (2021).
Google Scholar
Lauer, S. A. et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann. Intern. Med. 172, 577–582 (2020).
Google Scholar
Elias, C., Sekri, A., Leblanc, P., Cucherat, M. & Vanhems, P. The incubation period of COVID-19: a meta-analysis. Int. J. Infect. Dis. 104, 708–710 (2021).
Google Scholar
Dhouib, W. et al. The incubation period during the pandemic of COVID-19: a systematic review and meta-analysis. Syst. Rev. 10, 101 (2021).
Google Scholar
Brandal, L. T. et al. Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. Eur. Surveill. 26, 2101147 (2021).
Google Scholar
Wu, Y. et al. Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis. JAMA Netw. Open 5, e2228008 (2022).
Google Scholar
Sun, K. et al. Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science 371, eabe2424 (2021).
Google Scholar
Lavezzo, E. et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’. Nature 584, 425–429 (2020).
Google Scholar
Gudbjartsson, D. F. et al. Spread of SARS-CoV-2 in the Icelandic population. N. Engl. J. Med. 382, 2302–2315 (2020).
Google Scholar
Glenet, M. et al. Asymptomatic COVID-19 adult outpatients identified as significant viable SARS-CoV-2 shedders. Sci. Rep. 11, 20615 (2021).
Google Scholar
Wang, Y. et al. Characterization of an asymptomatic cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected individuals outside of Wuhan, China. Clin. Infect. Dis. 71, 2132–2138 (2020).
Google Scholar
Long, Q. X. et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 26, 1200–1204 (2020).
Google Scholar
Lee, S. et al. Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea. JAMA Intern. Med. 180, 1447–1452 (2020).
Google Scholar
Zhou, R. et al. Viral dynamics in asymptomatic patients with COVID-19. Int. J. Infect. Dis. 96, 288–290 (2020).
Google Scholar
Hall, S. M. et al. Comparison of anterior nares CT values in asymptomatic and symptomatic individuals diagnosed with SARS-CoV-2 in a university screening program. PLoS ONE 17, e0270694 (2022).
Google Scholar
Kissler, S. M. et al. Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies. PLoS Biol. 19, e3001333 (2021).
Google Scholar
Tallmadge, R. L. et al. Viral RNA load and infectivity of SARS-CoV-2 in paired respiratory and oral specimens from symptomatic, asymptomatic, or postsymptomatic individuals. Microbiol. Spectr. 10, e0226421 (2022).
Google Scholar
Marks, M. et al. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Lancet Infect. Dis. 21, 629–636 (2021).
Google Scholar
Marc, A. et al. Quantifying the relationship between SARS-CoV-2 viral load and infectiousness. eLife https://doi.org/10.7554/eLife.69302 (2021).
Google Scholar
Cheng, H. Y. et al. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern. Med. 180, 1156–1163 (2020).
Google Scholar
Mugglestone, M. A. et al. Presymptomatic, asymptomatic and post-symptomatic transmission of SARS-CoV-2: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance. BMC Infect. Dis. 22, 453 (2022).
Google Scholar
Eyre, D. W. et al. Effect of Covid-19 vaccination on transmission of Alpha and Delta variants. N. Engl. J. Med. 386, 744–756 (2022).
Google Scholar
Prunas, O. et al. Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel. Science 375, 1151–1154 (2022).
Google Scholar
Lyngse, F. P. et al. Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark. Nat. Commun. 13, 5760 (2022).
Google Scholar
Leung, N. H. L. Transmissibility and transmission of respiratory viruses. Nat. Rev. Microbiol. 19, 528–545 (2021).
Google Scholar
Alihsan, B. et al. The efficacy of facemasks in the prevention of COVID-19: a systematic review. Preprint at medRxiv https://doi.org/10.1101/2022.07.28.22278153 (2022).
Google Scholar
Hu, Z. et al. Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study. Elife 11, e77943 (2022).
Google Scholar
Chen, P. Z. et al. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols. eLife https://doi.org/10.7554/eLife.65774 (2021).
Google Scholar
Adam, D. C. et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat. Med. 26, 1714–1719 (2020).
Google Scholar
Guo, Z. et al. Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea. J. Infect. 85, e77–e79 (2022).
Google Scholar
Guo, Z. et al. Superspreading potential of COVID-19 outbreak seeded by Omicron variants of SARS-CoV-2 in Hong Kong. J. Travel Med. 29, taac049 (2022).
Google Scholar
Althouse, B. M. et al. Superspreading events in the transmission dynamics of SARS-CoV-2: opportunities for interventions and control. PLoS Biol. 18, e3000897 (2020).
Google Scholar
Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403–416 (2021).
Google Scholar
Lopez Bernal, J. et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N. Engl. J. Med. 385, 585–594 (2021).
Google Scholar
Feikin, D. R. et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet 399, 924–944 (2022).
Google Scholar
Belik, M. et al. Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants. Nat. Commun. 13, 2476 (2022).
Google Scholar
Pegu, A. et al. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science 373, 1372–1377 (2021).
Google Scholar
Lipsitch, M., Krammer, F., Regev-Yochay, G., Lustig, Y. & Balicer, R. D. SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact. Nat. Rev. Immunol. 22, 57–65 (2022).
Google Scholar
Mostaghimi, D., Valdez, C. N., Larson, H. T., Kalinich, C. C. & Iwasaki, A. Prevention of host-to-host transmission by SARS-CoV-2 vaccines. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(21)00472-2 (2021).
Google Scholar
Russell, M. W., Moldoveanu, Z., Ogra, P. L. & Mestecky, J. Mucosal immunity in COVID-19: a neglected but critical aspect of SARS-CoV-2 infection. Front. Immunol. 11, 611337 (2020).
Google Scholar
Sheikh-Mohamed, S. et al. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection. Mucosal Immunol. 15, 799–808 (2022).
Google Scholar
Collier, A. Y. et al. Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 Delta variant. Sci. Transl Med. 14, eabn6150 (2022).
Google Scholar
Pouwels, K. B. et al. Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Nat. Med. 27, 2127–2135 (2021).
Google Scholar
Singanayagam, A. et al. Community transmission and viral load kinetics of the SARS-CoV-2 Delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect. Dis. 22, 183–195 (2021).
Google Scholar
Levine-Tiefenbrun, M. et al. Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2. Nat. Med. 27, 2108–2110 (2021).
Google Scholar
Emary, K. R. W. et al. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet 397, 1351–1362 (2021).
Google Scholar
Chia, P. Y. et al. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study. Clin. Microbiol. Infect. 28, 612.e1–612.e7 (2021).
Google Scholar
Garcia-Knight, M. et al. Infectious viral shedding of SARS-CoV-2 Delta following vaccination: a longitudinal cohort study. PLoS Pathog. 18, e1010802 (2022).
Google Scholar
Peña-Hernández, M. A. et al. Comparison of infectious SARS-CoV-2 from the nasopharynx of vaccinated and unvaccinated individuals. Preprint at medRxiv https://doi.org/10.1101/2021.12.28.21268460 (2022).
Google Scholar
Shamier, M. C. et al. Virological characteristics of SARS-CoV-2 vaccine breakthrough infections in health care workers. Preprint at medRxiv https://doi.org/10.1101/2021.08.20.21262158 (2021).
Google Scholar
Jung, J. et al. Transmission and infectious SARS-CoV-2 shedding kinetics in vaccinated and unvaccinated individuals. JAMA Netw. Open 5, e2213606 (2022).
Google Scholar
Hirotsu, Y. et al. Similar viral loads in Omicron infections regardless of vaccination status. Preprint at medRxiv https://doi.org/10.1101/2022.04.19.22274005 (2022).
Google Scholar
Letizia, A. G. et al. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study. Lancet Respir. Med. 9, 712–720 (2021).
Google Scholar
Pulliam, J. R. C. et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science 376, eabn4947 (2022).
Google Scholar
Harris, R. J. et al. Effect of vaccination on household transmission of SARS-CoV-2 in England. N. Engl. J. Med. 385, 759–760 (2021).
Google Scholar
Bates, T. A. et al. Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants. Sci. Immunol. 7, eabn8014 (2022).
Google Scholar
Wratil, P. R. et al. Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. Nat. Med. 28, 496–503 (2022).
Google Scholar
Malato, J. et al. Risk of BA.5 infection among persons exposed to previous SARS-CoV-2 variants. N. Engl. J. Med. 387, 953–954 (2022).
Google Scholar
Cao, Y. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608, 593–602 (2022).
Google Scholar
Hassan, A. O. et al. A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2. Cell 183, 169–184 (2020).
Google Scholar
Lapuente, D. et al. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization. Nat. Commun. 12, 6871 (2021).
Google Scholar
Afkhami, S. et al. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell 185, 896–915 (2022).
Google Scholar
Grubaugh, N. D. & Hodcroft, E. B. Public health actions to control new SARS-CoV-2 variants. Cell 184, 1127–1132 (2021).
Google Scholar
Carreño, J. M. et al. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature 602, 682–688 (2022).
Google Scholar
Ashcroft, P., Lehtinen, S. & Bonhoeffer, S. Test-trace-isolate-quarantine (TTIQ) intervention strategies after symptomatic COVID-19 case identification. PLoS ONE 17, e0263597 (2022).
Google Scholar
Santos Bravo, M. et al. Viral culture confirmed SARS-CoV-2 subgenomic RNA value as a good surrogate marker of infectivity. J. Clin. Microbiol. 60, e0160921 (2022).
Google Scholar
Kim, J. Y. et al. Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19. Clin. Microbiol. Infect. 28, 101–106 (2022).
Google Scholar
Alexandersen, S. & Chamings, A. SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication. Nat. Commun. 11, 6059 (2020).
Google Scholar
Bonenfant, G. et al. Surveillance and correlation of SARS-CoV-2 viral RNA, antigen, virus isolation, and self-reported symptoms in a longitudinal study with daily sampling. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciac282 (2022).
Google Scholar
Peeling, R. W., Heymann, D. L., Teo, Y. Y. & Garcia, P. J. Diagnostics for COVID-19: moving from pandemic response to control. Lancet 399, 757–768 (2022).
Google Scholar
Pilarowski, G. et al. Performance characteristics of a rapid severe acute respiratory syndrome coronavirus 2 antigen detection assay at a public plaza testing site in San Francisco. J. Infect. Dis. 223, 1139–1144 (2021).
Google Scholar
Leber, W. et al. Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2). EClinicalMedicine 38, 101011 (2021).
Google Scholar
Kohmer, N. et al. The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro. J. Clin. Med. https://doi.org/10.3390/jcm10020328 (2021).
Google Scholar
Wang, W. et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 323, 1843–1844 (2020).
Google Scholar
Lee, R. A., Herigon, J. C., Benedetti, A., Pollock, N. R. & Denkinger, C. M. Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS-CoV-2 molecular detection: a systematic review and meta-analysis. J. Clin. Microbiol. 59, e02881-20 (2021).
Tsang, N. N. Y. et al. Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis. Lancet Infect. Dis. 21, 1233–1245 (2021).
Google Scholar
Peto, T. COVID-19: rapid antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation of sensitivity and specificity for mass-testing. EClinicalMedicine 36, 100924 (2021).
Google Scholar
Hay, J. A. et al. Estimating epidemiologic dynamics from cross-sectional viral load distributions. Science 373, eabh0635 (2021).
Google Scholar
Peccia, J. et al. Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics. Nat. Biotechnol. 38, 1164–1167 (2020).
Google Scholar
Xin, H. et al. The incubation period distribution of coronavirus disease 2019: a systematic review and meta-analysis. Clin. Infect. Dis. 73, 2344–2352 (2021).
Google Scholar
Yu, I. T. et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N. Engl. J. Med. 350, 1731–1739 (2004).
Google Scholar
Cheng, P. K. et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet 363, 1699–1700 (2004).
Google Scholar
Peiris, J. S. et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 1767–1772 (2003).
Google Scholar
Chan, P. K. S. et al. Laboratory diagnosis of SARS. Emerg. Infect. Dis. 10, 825–831 (2004).
Google Scholar
Liu, W. et al. Long-term SARS coronavirus excretion from patient cohort, China. Emerg. Infect. Dis. 10, 1841–1843 (2004).
Google Scholar
Xu, D. et al. Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. Eur. J. Clin. Microbiol. Infect. Dis. 24, 165–171 (2005).
Google Scholar
V’Kovski, P. et al. Disparate temperature-dependent virus–host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium. PLoS Biol. 19, e3001158 (2021).
Google Scholar
Pitzer, V. E., Leung, G. M. & Lipsitch, M. Estimating variability in the transmission of severe acute respiratory syndrome to household contacts in Hong Kong, China. Am. J. Epidemiol. 166, 355–363 (2007).
Google Scholar
Riley, S. et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 300, 1961–1966 (2003).
Google Scholar
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. & Fouchier, R. A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814–1820 (2012).
Google Scholar
Breban, R., Riou, J. & Fontanet, A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 382, 694–699 (2013).
Google Scholar
Oh, M. D. et al. Viral load kinetics of MERS coronavirus infection. N. Engl. J. Med. 375, 1303–1305 (2016).
Google Scholar
Corman, V. M. et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus Infection. Clin. Infect. Dis. 62, 477–483 (2016).
Google Scholar
Min, C.-K. et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci. Rep. 6, 25359 (2016).
Google Scholar
Ip, D. K. et al. Viral shedding and transmission potential of asymptomatic and paucisymptomatic influenza virus infections in the community. Clin. Infect. Dis. 64, 736–742 (2017).
Google Scholar
Carrat, F. et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am. J. Epidemiol. 167, 775–785 (2008).
Google Scholar
Pawelek, K. A. et al. Modeling within-host dynamics of influenza virus infection including immune responses. PLoS Comput. Biol. 8, e1002588 (2012).
Google Scholar
Ip, D. K. M. et al. The dynamic relationship between clinical symptomatology and viral shedding in naturally acquired seasonal and pandemic influenza virus infections. Clin. Infect. Dis. 62, 431–437 (2016).
Google Scholar
Nair, H. et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375, 1545–1555 (2010).
Google Scholar
Bagga, B. et al. Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals. Antivir. Ther. 18, 785–791 (2013).
Google Scholar
DeVincenzo, J. P. et al. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 182, 1305–1314 (2010).
Google Scholar
Kutter, J. S. et al. Small quantities of respiratory syncytial virus RNA only in large droplets around infants hospitalized with acute respiratory infections. Antimicrob. Resist. Infect. Control 10, 100 (2021).
Google Scholar
Source: news.google.com